VACCINEX, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vaccinex, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Vaccinex, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $15K, a 92% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $15K -$173K -92% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $59K -$170K -74.2% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $103K -$167K -61.9% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $146K -$164K -52.9% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $188K -$163K -46.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $229K +$172K +302% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $270K +$171K +173% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $310K +$169K +120% Dec 31, 2022 10-K/A 2024-04-25
Q3 2022 $351K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $57K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $99K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $141K Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.